Review



cta protein array  (Sengenics Corporation Pte)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Sengenics Corporation Pte cta protein array
    Antigen reactivities identified with ovarian cancer cohort 1 using <t> Sengenics </t> <t> CTA protein </t> arrays. Ovarian cancer ASC probes ( n = 11, A–K) and selected matched sera ( n = 5) were screened using <t> Sengenics </t> <t> CTA protein </t> arrays.
    Cta Protein Array, supplied by Sengenics Corporation Pte, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cta+protein+array/cta+protein+array/pmc08538754-157-2-1
    Average 90 stars, based on 1 article reviews
    cta protein array - by Bioz Stars, 2026-10
    90/100 stars

    Images

    1) Product Images from "Identification of Tumor Antigens in Ovarian Cancers Using Local and Circulating Tumor-Specific Antibodies"

    Article Title: Identification of Tumor Antigens in Ovarian Cancers Using Local and Circulating Tumor-Specific Antibodies

    Journal: International Journal of Molecular Sciences

    doi: 10.3390/ijms222011220

    Antigen reactivities identified with ovarian cancer cohort 1 using Sengenics CTA protein arrays. Ovarian cancer ASC probes ( n = 11, A–K) and selected matched sera ( n = 5) were screened using Sengenics CTA protein arrays.
    Figure Legend Snippet: Antigen reactivities identified with ovarian cancer cohort 1 using Sengenics CTA protein arrays. Ovarian cancer ASC probes ( n = 11, A–K) and selected matched sera ( n = 5) were screened using Sengenics CTA protein arrays.

    Techniques Used:

    Study design diagram. Ovarian cancer cohort 1 and selected healthy and benign controls were screened using the CDI HuProt TM array and the Sengenics CTA protein array, which led to the identification of 50 candidate antigens. A custom array was developed and used to screen ovarian cancer cohort 2, as well as healthy and benign controls.
    Figure Legend Snippet: Study design diagram. Ovarian cancer cohort 1 and selected healthy and benign controls were screened using the CDI HuProt TM array and the Sengenics CTA protein array, which led to the identification of 50 candidate antigens. A custom array was developed and used to screen ovarian cancer cohort 2, as well as healthy and benign controls.

    Techniques Used: Protein Array

    Related Articles

    Protein Array:

    Article Title: Identification of Tumor Antigens in Ovarian Cancers Using Local and Circulating Tumor-Specific Antibodies
    Article Snippet: .. This study utilized two commercial high-density protein microarrays—the CDI HuProt TM array (16,086 human proteins and protein isoforms) and the Sengenics CTA protein array (257 cancer-testis and -associated antigens)—to screen ASC probes and matched sera from cohort 1 ( n = 11) to identify candidate antigens. ..

    Article Title: Identification of Tumor Antigens in Ovarian Cancers Using Local and Circulating Tumor-Specific Antibodies
    Article Snippet: .. The Sengenics CTA protein array included 256 cancer-testis and associated antigens and was used to screen ASC probes at a 1:2 dilution and serum at a 1:800 dilution. .. While some protein content was shared between the HuProt TM and CTA arrays (189 antigens), the protein cloning and expression methods used by each array platform differed (N-terminal GST-His-tagged proteins produced using the pEGH-A expression vector in a Saccharomyces cerevisiae strain versus BCCP-tagged fusion proteins produced in SF9 insect cells and biotinylated in vivo, respectively) [ ].





    Similar Products

    cta protein array  (Sengenics Corporation Pte)
    90
    Sengenics Corporation Pte cta protein array
    Antigen reactivities identified with ovarian cancer cohort 1 using <t> Sengenics </t> <t> CTA protein </t> arrays. Ovarian cancer ASC probes ( n = 11, A–K) and selected matched sera ( n = 5) were screened using <t> Sengenics </t> <t> CTA protein </t> arrays.
    Cta Protein Array, supplied by Sengenics Corporation Pte, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cta+protein+array/cta+protein+array/pmc08538754-157-2-1
    Average 90 stars, based on 1 article reviews
    cta protein array - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    cancer-testis antigens (cta) protein array  (Sengenics Corporation Pte)
    90
    Sengenics Corporation Pte cancer-testis antigens (cta) protein array
    Antigen reactivities identified with ovarian cancer cohort 1 using <t> Sengenics </t> <t> CTA protein </t> arrays. Ovarian cancer ASC probes ( n = 11, A–K) and selected matched sera ( n = 5) were screened using <t> Sengenics </t> <t> CTA protein </t> arrays.
    Cancer Testis Antigens (Cta) Protein Array, supplied by Sengenics Corporation Pte, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cta+protein+array/cancer+testis+antigens++cta++protein+array/pmc08538754-154-51-56
    Average 90 stars, based on 1 article reviews
    cancer-testis antigens (cta) protein array - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Antigen reactivities identified with ovarian cancer cohort 1 using Sengenics CTA protein arrays. Ovarian cancer ASC probes ( n = 11, A–K) and selected matched sera ( n = 5) were screened using Sengenics CTA protein arrays.

    Journal: International Journal of Molecular Sciences

    Article Title: Identification of Tumor Antigens in Ovarian Cancers Using Local and Circulating Tumor-Specific Antibodies

    doi: 10.3390/ijms222011220

    Figure Lengend Snippet: Antigen reactivities identified with ovarian cancer cohort 1 using Sengenics CTA protein arrays. Ovarian cancer ASC probes ( n = 11, A–K) and selected matched sera ( n = 5) were screened using Sengenics CTA protein arrays.

    Article Snippet: The Sengenics CTA protein array included 256 cancer-testis and associated antigens and was used to screen ASC probes at a 1:2 dilution and serum at a 1:800 dilution.

    Techniques:

    Study design diagram. Ovarian cancer cohort 1 and selected healthy and benign controls were screened using the CDI HuProt TM array and the Sengenics CTA protein array, which led to the identification of 50 candidate antigens. A custom array was developed and used to screen ovarian cancer cohort 2, as well as healthy and benign controls.

    Journal: International Journal of Molecular Sciences

    Article Title: Identification of Tumor Antigens in Ovarian Cancers Using Local and Circulating Tumor-Specific Antibodies

    doi: 10.3390/ijms222011220

    Figure Lengend Snippet: Study design diagram. Ovarian cancer cohort 1 and selected healthy and benign controls were screened using the CDI HuProt TM array and the Sengenics CTA protein array, which led to the identification of 50 candidate antigens. A custom array was developed and used to screen ovarian cancer cohort 2, as well as healthy and benign controls.

    Article Snippet: The Sengenics CTA protein array included 256 cancer-testis and associated antigens and was used to screen ASC probes at a 1:2 dilution and serum at a 1:800 dilution.

    Techniques: Protein Array